Aceclofenac
CAS No. 89796-99-6
Aceclofenac( Aceclofenac | YT-919 | YT 919 | YT919 | Airtal | Beofenac )
Catalog No. M16460 CAS No. 89796-99-6
Aceclofenac is a non-steroidal anti-inflammatory drug (NSAID) analog of Diclofenac.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 28 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | 28 | In Stock |
|
Biological Information
-
Product NameAceclofenac
-
NoteResearch use only, not for human use.
-
Brief DescriptionAceclofenac is a non-steroidal anti-inflammatory drug (NSAID) analog of Diclofenac.
-
DescriptionAceclofenac is a non-steroidal anti-inflammatory drug (NSAID) analog of Diclofenac. It is used for the relief of pain and inflammation in rheumatoid arthritis, osteoarthritis and ankylosing spondylitis. (In Vitro):Aceclofenac (1-30 μM; 72 hours) significantly decreases interleukin-6 production and fully blocks prostaglandin E2 synthesis by IL-1β- or LPS-stimulated human chondrocytes.Aceclofenac inhibits COX-1 with IC50 values superior to 100 μM, but decreases by 50% COX-2 activity at the concentration of 0.77 μM in the whole blood test.Aceclofenac increases the synthesis of interleukin 1 receptor antagonist and decreases the production of nitric oxide in human articular chondrocytes.(In Vivo):Aceclofenac exhibits Cmax (4.59 μg/mL) following oral administration (rat 20 mg/kg).Aceclofenac exhibits terminal elimination half-life (rat 3.24 h) due to high plasma clearance (rat 1.10 L/h/kg) following intravenous injection (rat 10 mg/kg).
-
In VitroAceclofenac (1-30 μM; 72 hours) significantly decreases interleukin-6 production and fully blocks prostaglandin E2 synthesis by IL-1β- or LPS-stimulated human chondrocytes.Aceclofenac inhibits COX-1 with IC50 values superior to 100 μM, but decreases by 50% COX-2 activity at the concentration of 0.77 μM in the whole blood test.Aceclofenac increases the synthesis of interleukin 1 receptor antagonist and decreases the production of nitric oxide in human articular chondrocytes.
-
In VivoAceclofenac exhibits Cmax (4.59 μg/mL) following oral administration (rat 20 mg/kg).Aceclofenac exhibits terminal elimination half-life (rat 3.24 h) due to high plasma clearance (rat 1.10 L/h/kg) following intravenous injection (rat 10 mg/kg). Animal Model:Male Sprague-Dawley rats weighing 32-340 g Dosage:10 mg/kg for i.v., 20 mg/kg for p.o. (Pharmacokinetic Analysis) Administration:Oral administration and intravenous injection Result:T1/2 (3.24 h), Cmax (4.59 μg/mL for p.o.).
-
SynonymsAceclofenac | YT-919 | YT 919 | YT919 | Airtal | Beofenac
-
PathwayChromatin/Epigenetic
-
TargetCOX
-
RecptorCOX
-
Research AreaInflammation/Immunology
-
Indication——
Chemical Information
-
CAS Number89796-99-6
-
Formula Weight354.18
-
Molecular FormulaC16H13Cl2NO4
-
Purity>98% (HPLC)
-
SolubilityDMSO: 10 mM
-
SMILESO=C(OCC(O)=O)CC1=CC=CC=C1NC2=C(Cl)C=CC=C2Cl
-
Chemical Name2-(2-(2-((2,6-dichlorophenyl)amino)phenyl)acetoxy)acetic acid
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Ganesh M, et al. Int J Biol Macromol. 2015 Mar;74:310-7.
molnova catalog
related products
-
Hamaudol
Hamaudol is a chromone isolated from Saposhnikovia divaricata,has analgesic and anti-inflammary activities, it showed inhibitory activity on COX-1 and COX-2 activities with values of 0.30, 0.57 mM, respectively.The CHCl3 extract of the root of Angelica japonica showed high inhibitory activity against human gastric adenocarcinoma (MK-1) cell growth.
-
JNJ-42153605
JNJ-42153605 is a mGlu2 receptor positive allosteric modulator (EC50: 17 nM).
-
Valdecoxib
Valdecoxib was removed from the Canadian, U.S., and E.U. markets in 2005 due to concerns about possible increased risk of heart attack and stroke.
Cart
sales@molnova.com